| 摘要 |
The present invention relates to the use of alfuzosin and its pharmaceutically acceptable salts for manufacturing drugs intended for the treatment of disorders induced by smooth muscle contraction in the urinary tract, excluding contraction of alpha -adrenergic origin. |
